Effects of fatty acids on skeletal muscle cell differentiation in vitro

Division of Nutritional Sciences, University of Nottingham, School of Biosciences, Sutton Bonington Campus, Loughborough, UK.
British Journal Of Nutrition (Impact Factor: 3.45). 04/2006; 95(3):623-30. DOI: 10.1079/BJN20051711
Source: PubMed


Previous studies have shown stimulatory effects of linoleic acid (LA, C18:2) on differentiation of rat muscle cells in culture (Allen et al. 1985), but there appears to be little investigation of the effects of other fatty acids. The present study therefore compared the effects of different fatty acids on muscle cell differentiation in vitro. L6 myoblasts were cultured (Dulbecco's Modified Eagles Medium + 10 % fetal calf serum) in six-well plates until 80 % confluent (day 0). Cells were then either harvested or the medium switched to differentiation medium (Dulbecco's Modified Eagles Medium+2 % horse serum), supplemented with fatty acid or drug treatments. Cells were harvested on days 0-5 and assayed for creatine kinase (CK), protein and DNA contents, to give a measure of differentiation (CK/DNA). Initial studies indicated a stimulatory effect of the cis9,trans11 (c9,t11) isomer of conjugated linoleic acid (CLA) relative to control. By contrast, the trans10,cis12 (t10,c12) isomer of CLA inhibited differentiation. Further experiments indicated that inhibition of differentiation by the t10,c12 CLA isomer was dose-dependent (up to 200 microm) and may be via increased cell proliferation. LA and c9,t11 CLA stimulated differentiation at low concentrations (up to 50 microm), but inhibited differentiation at high concentrations (200 microm). In contrast, oleic acid stimulated differentiation at all concentrations, whereas the saturated fatty acid, palmitic acid, had no effect. The mechanism appeared not to involve either peroxisome proliferator-activated receptors alpha or gamma. The data suggest that only unsaturated fatty acids have an effect and the presence or absence of a cis-9 double bond may be important.

Download full-text


Available from: John M. Brameld
  • Source
    • "Absorption at 340 nm was measured at 30 8C every 5 min over a 30-min period. DNA content (mg/well) of the thawed cell lysate was measured using a fluorescence plate reader assay adapted from Rago et al. (Rago et al. 1990, Hurley et al. 2006). Protein content (mg/well) was measured via the Lowry method (Lowry et al. 1951) adapted for 96-well plate format. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Fat infiltration within muscle is one of a number of features of vitamin D deficiency which leads to a decline in muscle functionality. The origin of this fat is unclear but one possibility is that it forms from myogenic precursor cells present in the muscle, which transdifferentiate into mature adipocytes. The current study examined the effect of the active form of vitamin D3, 1,25 dihydroxyvitamin D3 (1,25(OH)2D3), on the capacity of the C2C12 muscle cell line to differentiate towards the myogenic and adipogenic lineages. Cells were cultured in myogenic or adipogenic differentiation media containing increasing concentrations (0, 10-13, 10-11, 10-9, 10-7 or 10-5M) of 1,25(OH)2D3 for up to 6 days and markers of muscle and fat development measured.Mature myofibres were formed in both adipogenic and myogenic media, but fat droplets were only observed in adipogenic media. Relative to controls, low physiological concentrations (10-13 and 10-11M) of 1,25(OH)2D3 increased fat droplet accumulation, whereas high physiological (10-9M) and supraphysiological concentrations (≥10-7M) inhibited fat accumulation. This increased accumulation of fat with low physiological concentrations (10-13 and 10-11M) was associated with a sequential up-regulation of PPARγ2 and FABP4 mRNA, indicating formation of adipocytes, whereas higher concentrations (≥10-9M) reduced all these effects, and the highest concentration (10-5M) appeared to have toxic effects.This is the first study to demonstrate dose-dependent effects of 1,25(OH)2D3 on the transdifferentiation of muscle cells into adipose cells. Low physiological concentrations (possibly mimicking a deficient state) induced adipogenesis, whereas higher (physiological and supraphysiological) concentrations attenuated this effect.
    Full-text · Article · Jan 2013 · Journal of Endocrinology
  • Source
    • "Specific nutrients. Due to the effects of maternal undernutrition on muscle cell proliferation/differentiation observed in the various in vivo studies, Brameld and co-workers have also investigated direct effects of nutrients on muscle differentiation in vitro (Hurley et al., 2006). They found that a number of unsaturated fatty acids (both poly-and mono-unsaturated) altered differentiation of L6 muscle cells, with no effect of palmitic acid, the only saturated fatty acid studied. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Skeletal muscle development in vertebrates - also termed myogenesis - is a highly integrated process. Evidence to date indicates that the processes are very similar across mammals, poultry and fish, although the timings of the various steps differ considerably. Myogenesis is regulated by the myogenic regulatory factors and consists of two to three distinct phases when different fibre populations appear. The critical times when myogenesis is prone to hormonal or environmental influences depend largely on the developmental stage. One of the main mechanisms for both genetic and environmental effects on muscle fibre development is via the direct action of the growth hormone-insulin-like growth factor (GH-IGF) axis. In mammals and poultry, postnatal growth and function of muscles relate mainly to the hypertrophy of the fibres formed during myogenesis and to their fibre-type composition in terms of metabolic and contractile properties, whereas in fish hyperplasia still plays a major role. Candidate genes that are important in skeletal muscle development, for instance, encode for IGFs and IGF-binding proteins, myosin heavy chain isoforms, troponin T, myosin light chain and others have been identified. In mammals, nutritional supply in utero affects myogenesis and the GH-IGF axis may have an indirect action through the partitioning of nutrients towards the gravid uterus. Impaired myogenesis resulting in low skeletal myofibre numbers is considered one of the main reasons for negative long-term consequences of intrauterine growth retardation. Severe undernutrition in utero due to natural variation in litter or twin-bearing species or insufficient maternal nutrient supply may impair myogenesis and adversely affect carcass quality later in terms of reduced lean and increased fat deposition in the progeny. On the other hand, increases in maternal feed intake above standard requirement seem to have no beneficial effects on the growth of the progeny with myogenesis not or only slightly affected. Initial studies on low and high maternal protein feeding are published. Although there are only a few studies, first results also reveal an influence of nutrition on skeletal muscle development in fish and poultry. Finally, environmental temperature has been identified as a critical factor for growth and development of skeletal muscle in both fish and poultry.
    Full-text · Article · Apr 2011 · animal
  • Source
    • "The cells were subjected to the treatment of different concentrations of BBR or the combination of BBR and palmitic acid. Berberine was dissolved in dimethyl sulfoxide (DMSO), and palmitic acid was provided in a form of fatty acid–albumin complex [29] [35]. The control cells were treated with equal amount of the vehicle. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The plant alkaloid berberine (BBR) has been reported to have antidiabetic effect in humans and animals. However, the mechanism of action is not well understood. The present study was conducted to determine the effect and mechanism of action of BBR on the free-fatty-acid (FFA)-induced insulin resistance in muscle cells. The FFA-induced insulin-resistant cell model was established in L6 myotubes by treating them with 250 mumol/L of palmitic acid. The inclusion of FFA in the medium increased peroxisome proliferator-activated receptor gamma (PPARgamma) and fatty acid transferase (FAT/CD36) expressions by 26% and 50% and decreased glucose consumption by 43% and insulin-mediated glucose uptake by 63%, respectively. Berberine treatment increased the glucose consumption and insulin-stimulated glucose uptake in normal cells and improved glucose uptake in the FFA-induced insulin-resistant cells. The improved glucose uptake by BBR was accompanied with a dose-dependent decrease in PPARgamma and FAT/CD36 protein expressions. In insulin-resistant myotubes, BBR (5 micromol/L) decreased PPARgamma and FAT/CD36 proteins by 31% and 24%, whereas PPARgamma antagonist GW9662 reduced both proteins by 56% and 46%, respectively. In contrast, PPARgamma agonist rosiglitazone increased the expression of PPARgamma and FAT/CD36 by 34% and 21%, respectively. Our results suggest that BBR improves the FFA-induced insulin resistance in myotubes through inhibiting fatty acid uptake at least in part by reducing PPARgamma and FAT/CD36 expressions.
    Full-text · Article · Sep 2009 · Metabolism: clinical and experimental
Show more